ArticleHuman vaccines & immunotherapeutics2022

Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspective.

Angus Forster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.